Press Releases
First phase of enrollment of single device for CCM® and ICD therapy complete
By Impulse Dynamics · Via GlobeNewswire · April 28, 2025
New Analyses of PSC Data from Phase 2 SPRING Trial Show that Treatment with Nebokitug Is Associated with Dose-Dependent and Significant Improvements in Multiple Inflammatory and Fibrotic Biomarkers
By Chemomab Therapeutics · Via GlobeNewswire · April 28, 2025
-- PCRX-201 demonstrated two years of clinically meaningful improvements in pain, stiffness and function across all structural severity subgroups, including advanced disease --
By Pacira BioSciences · Via GlobeNewswire · April 28, 2025
Strengthens Executive Leadership Team to Support Growth Strategy
Via ACCESS Newswire · April 28, 2025
SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the selection of IL15 superagonist (Il15-IL15Ra) as the first payload to be delivered into tumors using its systemic antitumor virotherapy platform, RTNova. New preclinical data were presented at the American Association for Cancer Research (AACR) Annual Meeting on April 27, 2025, in Chicago, IL.
By Calidi Biotherapeutics, Inc · Via GlobeNewswire · April 28, 2025
Officials join Republican U.S. Representative Young Kim for ribbon cutting event to celebrate new solar projects at low-income apartment communities in Orange County that provide immediate utility bill savings to hundreds of working families
By Sunrun Inc. · Via GlobeNewswire · April 28, 2025
NEWPORT BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Northstrive Biosciences Inc. (“Northstrive”), a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”), is proud to announce that Co-Founder Deniel Mero was recently featured in an exclusive interview hosted by Bear Bull Traders, a leading global online stock trading community for professional and aspiring traders.
By PMGC Holdings Inc. · Via GlobeNewswire · April 28, 2025
- Biotech luminary to mentor C-suite and provide strategic guidance -
By Adagene Inc. · Via GlobeNewswire · April 28, 2025
FLORHAM PARK, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that the company will present real-world data for its first-in-class treatment VOQUEZNA® (vonoprazan) at Digestive Disease Week® (DDW) being held May 3–6, 2025, in San Diego, CA. VOQUEZNA is the first and only treatment of its kind approved by the U.S. Food and Drug Administration for use in adults for the relief of heartburn associated with Non-Erosive GERD and for the treatment of all severities of Erosive Esophagitis (EE), commonly referred to as Erosive GERD, and relief of related heartburn.
By Phathom Pharmaceuticals · Via GlobeNewswire · April 28, 2025
Accenture (NYSE: ACN) has introduced Trusted Agent Huddle™ to allow first-of-its-kind multi-system agent collaboration across the enterprise.
By Accenture · Via Business Wire · April 28, 2025
The "Report on Emerging Technology Application for Intelligent Vehicle, 2024-2025" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · April 28, 2025
SEO.co Brings Full-Service SEO, White Label SEO, Link Building, and On-Page Optimization to the Greater Los Angeles Area
Via Press Release Distribution Service · April 28, 2025
SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent application with the U.S. Patent and Trademark Office (USPTO) focused on the neurology drug SPC-14, an intranasal compound for the treatment of Alzheimer’s disease (AD) exclusively licensed to Silo Pharma from Columbia University.
By Silo Pharma, Inc. · Via GlobeNewswire · April 28, 2025
SLINGERLANDS, N.Y., April 28, 2025 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions, today announced it has signed a definitive agreement for a secured debt facility and achieved key operational and financial milestones that support its path toward profitability and long-term growth.
By Plug Power, Inc. · Via GlobeNewswire · April 28, 2025
Denver, Colorado--(Newsfile Corp. - April 28, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of...
Via Newsfile · April 28, 2025
Putting the "Paper When Possible, Plastic When Useful" Principle into Action
Via ACCESS Newswire · April 28, 2025
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - Sranan Gold Corp. (CSE: SRAN) (FSE: P84) ("Sranan" or the "Company")...
Via Newsfile · April 28, 2025
Venu Holding Corporation ("VENU" or the “Company”) (NYSE American: VENU), a developer, owner, and operator of upscale live music venues and premium hospitality destinations, announces a major milestone for its Sunset Amphitheater at El Paso development. The El Paso City Council has approved key amendments to its unique public-private partnership with VENU, advancing the vision for a world-class, multi-seasonal 12,500-seat outdoor music venue in the heart of the Cohen Entertainment District.
By Venu Holding Corporation · Via Business Wire · April 28, 2025
MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer presented the ATH434-201 Phase 2 clinical trial results at the annual MSA Research Symposium hosted by University College London, Institute of Neurology in partnership with the MSA Trust of the U.K.
By ALTERITY THERAPEUTICS LIMITED · Via GlobeNewswire · April 28, 2025
WASHINGTON, April 28, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Josh Harris as a Senior Managing Director in the Private Equity practice within the firm’s Corporate Finance & Restructuring segment.
By FTI Consulting, Inc. · Via GlobeNewswire · April 28, 2025
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - Equinox Gold Corp. (TSX: EQX) (NYSE American: EQX) will announce its...
Via Newsfile · April 28, 2025
Cognitiv, the leading advanced performance partner powered by deep learning, today announced that marketing and media industry veteran Michael Kassan has joined its Board of Directors, bringing decades of media, marketing, and investing expertise to the company.
By Cognitiv · Via Business Wire · April 28, 2025
Following Tapcheck’s recent announcement of raising $225 million through combined equity and debt funding, the company has revealed a strategic partnership with Viventium, who offers an industry-leading payroll, HR, and compliance platform purpose-built for healthcare providers. Tapcheck, a leader in on-demand pay services, will integrate its earned wage access (EWA) feature directly into Viventium's robust payroll and HR platform, enabling seamless access to Tapcheck’s pay benefits for a swiftly growing healthcare workforce of more than 500,000.
By Tapcheck · Via Business Wire · April 28, 2025
OMAHA, Neb., April 28, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it will release its first quarter financial results on Monday, May 12, 2025, after market close. An earnings conference webcast will be held at 4:30 PM ET on the same day.
By Exodus · Via GlobeNewswire · April 28, 2025
Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a member of the Company’s Board of Directors. Mr. Ordal’s resignation, effective on April 25, 2025, was part of the Company’s ongoing commitment to refresh board composition on a regular basis in accordance with good corporate governance practices and was not the result of any disagreement with the Company’s management or the Board of Directors regarding any matter related to the Company or otherwise.
By FitLife Brands, Inc. · Via GlobeNewswire · April 28, 2025
Net Income Per Share (diluted) Increased by 37.7% Compared to 2023
By Tornado Infrastructure Equipment Ltd. · Via GlobeNewswire · April 28, 2025
Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations
By Crescent Biopharma · Via GlobeNewswire · April 28, 2025
Call to Be Held Wednesday, April 30 at 4:30 PM EST
By Nano Dimension Ltd. · Via GlobeNewswire · April 28, 2025
The "Analysis on Li Auto's Layout in Electrification, Connectivity, Intelligence and Sharing, 2024-2025" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · April 28, 2025
Company Announces Improved Q4 and Year-End Financial Results
Via ACCESS Newswire · April 28, 2025
Virsec, a leader in application and server workload protection for enterprises, announces the launch of OTTOGUARD.AI, the industry’s first patchless vulnerability mitigation platform. OTTOGUARD.AI decouples workload protection from patching cycles, so organizations can prevent cyber threats without delay.
By Virsec · Via Business Wire · April 28, 2025
The "Ireland Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2025 Update" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · April 28, 2025
Mini Desserts & “Big Daddy” Bites Are the Latest Recipe for a Viral Snack
By MGA Entertainment · Via GlobeNewswire · April 28, 2025
Following nearly eight years as Chairman and CEO, Hallal will oversee CEO transition and continue to guide strategic, financial and operational priorities as Executive Chairman of the Board of Directors
By ElevateBio · Via GlobeNewswire · April 28, 2025
Amberjack Capital Partners (“Amberjack”), a private equity firm investing in critical infrastructure services, today announced its partnership with Industrial Thermal Services, LLC (“ITS”), a premier provider of industrial heat treating and specialty services.
By Amberjack Capital Partners · Via Business Wire · April 28, 2025
The IPL machine is primarily known for its versatility in treating various skin conditions. One of its most popular applications is hair removal. The SHR hair removal IPL machine utilizes a unique method that combines the benefits of traditional laser hair removal with the efficiency of intense pulsed light. This technology allows for a more effective and less painful hair removal process, making it a preferred choice for many individuals seeking smooth skin.
Via AB Newswire · April 28, 2025
CHENGDU, China, April 28, 2025 (GLOBE NEWSWIRE) -- On April 29, on the eve of International Workers' Day, the countdown to the TWG 2025 Chengdu will reach the critical 100-day mark. Chengdu, the host city, is welcoming the upcoming The World Games 2025 Chengdu (TWG 2025 Chengdu) set to take place this August with a series of vibrant events, leveraging the international major festivals to amplify economic and social benefits.
By The Executive Committee and Coordination Committee of TWG 2025 Chengdu · Via GlobeNewswire · April 28, 2025
OCR Invoice AI has launched a new AI-powered platform that automates invoice data extraction for businesses. The software accurately processes PDFs, scans, and documents, helping companies save time and improve accounts payable efficiency.
Via Binary News Network · April 28, 2025
ocrinvoice.com announces the launch of its AI-powered invoice OCR software, helping businesses automate accounts payable processes. The platform extracts data from PDFs, scans, and documents with high accuracy and seamless system integration.
Via Binary News Network · April 28, 2025
When people think of wedding bands, gold or platinum likely comes to mind. However, an increasingly popular material on the market is neither of these and happens to be far more affordable than both. If they're on the hunt for something that's bold and unique, Tungsten Carbide might be the ideal ring option for them.
Via AB Newswire · April 28, 2025
Ouyuan Hardware Jewelry offers a wide selection of tungsten carbide rings, which are known for being the toughest and most scratch proof rings in the jewelry industry.One of the most popular choices in wedding jewelry in recent years, tungsten carbide rings have gained fame and increasing popularity as wedding bands because they are resistant to wear, they don’t scratch, they do not contain cobalt (which can cause reactions in sensitive skin), they are hypoallergenic and they are perfect for engraving.
Via AB Newswire · April 28, 2025
From strategic partnership to global employee action, EBC joins the global movement to end malaria for good
By EBC Financial Group · Via GlobeNewswire · April 28, 2025
In the $150 billion food delivery sector where 68% of customers rate temperature accuracy as their top concern, backpack delivery bags have evolved from simple carriers to precision thermal systems. These mobile kitchens now leverage NASA-inspired insulation tech to maintain foods at 60°C+ for 4 hours—critical for preserving Michelin-starred dishes during rush-hour deliveries. With the global third-party delivery market growing at 14% CAGR, thermal backpairs reduce customer complaints by 83% compared to standard boxes.
Via AB Newswire · April 28, 2025
Dubai, UAE, 28th April 2025, ZEX PR WIRE, In a Read more
Via Zexprwire · April 28, 2025
AcuityMD, the MedTech Intelligence Platform, today announced a new solution that will help MedTech companies and healthcare providers (HCPs) deliver new treatment options to more patients. Referral Pathways in AcuityMD Care Journeys provides comprehensive patient referral data so MedTech commercial teams can easily identify the physicians who can most benefit from their products and bring innovations to more patients.
By AcuityMD · Via Business Wire · April 28, 2025
Eldridge Real Estate Credit and Hillwood today announced the provision of two debt facilities for the development and construction of industrial units in Swanley and Park Royal, UK. These transactions total over £57.6 million, and they mark the second and third financings between Hillwood and Eldridge Real Estate Credit.
By Eldridge Real Estate Credit · Via Business Wire · April 28, 2025
India based Hindustan Zinc Limited, a Vedanta Group company and the world’s largest integrated zinc producer, announced its financial results for the year ended 31st March 2025 on 25th April 2025. The company recorded its ever-highest annual production of mined and refined metal of 1,095 KT and 1,052 KT respectively. The company delivered robust financials with FY25 revenue soaring 18% YoY to US$ 4,031 million. Hindustan Zinc also registered a robust FY25 EBITDA of US$ 2,066 million, up 28% YoY with an industry leading margin of c.51%, up 400 bps YoY. The company delivered robust full year profit after tax of US$ 1,224 million, up 33% YoY driven by 4-year lowest zinc cost of production at US$ 1,052/Mt. Hindustan Zinc recorded the highest-ever Return on Capital Employed^ of 58%, best in the industry. In FY25, Hindustan Zinc generated strong Free Cash Flow from operations (pre-capex) of US$ 1,630 million. In FY25, Hindustan Zinc delivered total shareholder returns of c.68% and ranks among the Top 3 companies in India’s Nifty Metal Index with a market capitalization of US$ 23 billion. The company has recently been included in the Futures & Options (F&O) segment on the National Stock Exchange (NSE). The company has consistently maintained an investment grade rating of AAA from CRISIL. Hindustan Zinc holds the second highest zinc reserves & resources globally with 25+ years of mine life and also surpassed 13.1 Mt of metal reserves (net of 1.2 Mt production) for the first time^.
By Hindustan Zinc Limited · Via Business Wire · April 28, 2025
Approval of Lynozyfic is based on data showing deep and durable responses in relapsed/refractory multiple myeloma
By Regeneron Pharmaceuticals, Inc. · Via GlobeNewswire · April 28, 2025
Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity
By AVACTA GROUP PLC · Via GlobeNewswire · April 28, 2025
Recognition highlights Narain’s impact in AI-driven drug discovery and biology-first innovation to the biopharma industry
By BPGbio · Via GlobeNewswire · April 28, 2025